These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23495048)

  • 1. Enhanced activity of lysosomal proteases in activated rat hepatic stellate cells is associated with a concomitant increase in the number of the mannose-6-phosphate/insulin-like growth factor II receptor.
    Mousavi SA; Fønhus MS; Kindberg GM; Tolleshaug H; Berg T
    Cell Biol Int; 2013 Jul; 37(7):703-12. PubMed ID: 23495048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered levels and distribution of IGF-II/M6P receptor and lysosomal enzymes in mutant APP and APP + PS1 transgenic mouse brains.
    Amritraj A; Hawkes C; Phinney AL; Mount HT; Scott CD; Westaway D; Kar S
    Neurobiol Aging; 2009 Jan; 30(1):54-70. PubMed ID: 17561313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells.
    Ghahary A; Tredget EE; Mi L; Yang L
    Exp Cell Res; 1999 Aug; 251(1):111-20. PubMed ID: 10438576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of the mannose 6-phosphate/ insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential.
    Xie S; Kang JX
    Med Sci Monit; 2002 Aug; 8(8):BR293-300. PubMed ID: 12165733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of mannose-6-phosphate on receptor-mediated endocytosis of insulin-like growth factor-II.
    Polychronakos C; Guyda HJ; Janthly U; Posner BI
    Endocrinology; 1990 Oct; 127(4):1861-6. PubMed ID: 2169404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor II/mannose 6-phosphate-receptor expression in liver and serum during acute CCl4 intoxication in the rat.
    De Bleser PJ; Scott CD; Niki T; Xu G; Wisse E; Geerts A
    Hepatology; 1996 Jun; 23(6):1530-7. PubMed ID: 8675174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
    Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R
    Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor II modulates the routing of cathepsin D in MCF-7 breast cancer cells.
    De Leon DD; Terry C; Asmerom Y; Nissley P
    Endocrinology; 1996 May; 137(5):1851-9. PubMed ID: 8612524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The insulin-like growth factor-II/mannose-6-phosphate receptor: structure, distribution and function in the central nervous system.
    Hawkes C; Kar S
    Brain Res Brain Res Rev; 2004 Mar; 44(2-3):117-40. PubMed ID: 15003389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II.
    Mathieu M; Rochefort H; Barenton B; Prebois C; Vignon F
    Mol Endocrinol; 1990 Sep; 4(9):1327-35. PubMed ID: 2172799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive properties of murine squamous carcinoma cells: secretion of matrix-degrading cathepsins is attributable to a deficiency in the mannose 6-phosphate/insulin-like growth factor II receptor.
    Lorenzo K; Ton P; Clark JL; Coulibaly S; Mach L
    Cancer Res; 2000 Aug; 60(15):4070-6. PubMed ID: 10945612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-2/mannose-6 phosphate receptors.
    El-Shewy HM; Luttrell LM
    Vitam Horm; 2009; 80():667-97. PubMed ID: 19251055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the IGF axis components in isolated rat hepatic stellate cells.
    Scharf JG; Knittel T; Dombrowski F; Müller L; Saile B; Braulke T; Hartmann H; Ramadori G
    Hepatology; 1998 May; 27(5):1275-84. PubMed ID: 9581681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factors (IGFs) stimulate the release of alpha 1-antichymotrypsin and soluble IGF-II/mannose 6-phosphate receptor from MCF7 breast cancer cells.
    Confort C; Rochefort H; Vignon F
    Endocrinology; 1995 Sep; 136(9):3759-66. PubMed ID: 7649082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of chondrocyte cathepsin B and L activities by insulin-like growth factor-II (IGF-II) and its Ser29 variant in vitro: possible role of the mannose 6-phosphate/IGF-II receptor.
    De Ceuninck F; Poiraudeau S; Pagano M; Tsagris L; Blanchard O; Willeput J; Corvol M
    Mol Cell Endocrinol; 1995 Sep; 113(2):205-13. PubMed ID: 8674828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethanol consumption decreases the synthesis of the mannose 6-phosphate/insulin-like growth factor II receptor but does not decrease its messenger RNA.
    Haorah J; MacDonald RG; Stoner JA; Donohue TM
    Biochem Pharmacol; 2003 Feb; 65(4):637-48. PubMed ID: 12566093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mannose-6-phosphate/insulin-like growth factor II receptor expression and tumor development.
    Hébert E
    Biosci Rep; 2006 Feb; 26(1):7-17. PubMed ID: 16779663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor in breast cancer cells alters tumorigenic properties in vitro and in vivo.
    Lee JS; Weiss J; Martin JL; Scott CD
    Int J Cancer; 2003 Nov; 107(4):564-70. PubMed ID: 14520693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol down-regulates the mannose-6-phosphate/insulin-like growth factor-II receptor gene and induces cathepsin-D in breast cancer cells: a receptor saturation mechanism to increase the secretion of lysosomal proenzymes.
    Mathieu M; Vignon F; Capony F; Rochefort H
    Mol Endocrinol; 1991 Jun; 5(6):815-22. PubMed ID: 1656243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Missorting of cathepsin B into the secretory compartment of CI-MPR/IGFII-deficient mice does not induce spontaneous trypsinogen activation but leads to enhanced trypsin activity during experimental pancreatitis--without affecting disease severity.
    Meister T; Niehues R; Hahn D; Domschke W; Sendler M; Lerch MM; Schnekenburger J
    J Physiol Pharmacol; 2010 Oct; 61(5):565-75. PubMed ID: 21081800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.